124 related articles for article (PubMed ID: 17195309)
1. Enoxaparin in elective percutaneous coronary intervention.
Hamon M; Riddell JW
N Engl J Med; 2006 Dec; 355(26):2788-9; author reply 2790-1. PubMed ID: 17195309
[No Abstract] [Full Text] [Related]
2. Enoxaparin in elective percutaneous coronary intervention.
Schuler J; Altenberger J; Heigert M
N Engl J Med; 2006 Dec; 355(26):2789-90; author reply 2790-1. PubMed ID: 17193723
[No Abstract] [Full Text] [Related]
3. Enoxaparin in elective percutaneous coronary intervention.
Pasceri V
N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195306
[No Abstract] [Full Text] [Related]
4. Enoxaparin in elective percutaneous coronary intervention.
Bhala N
N Engl J Med; 2006 Dec; 355(26):2788; author reply 2790-1. PubMed ID: 17192548
[No Abstract] [Full Text] [Related]
5. Enoxaparin in elective percutaneous coronary intervention.
Karthikeyan G
N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195310
[No Abstract] [Full Text] [Related]
6. Risk of bleeding after elective percutaneous coronary intervention.
O'Neill WW
N Engl J Med; 2006 Sep; 355(10):1058-60. PubMed ID: 16957154
[No Abstract] [Full Text] [Related]
7. Practical issues on the use of enoxaparin in elective and emergent percutaneous coronary intervention.
Díez JG
J Invasive Cardiol; 2008 Sep; 20(9):482-9. PubMed ID: 18762681
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
Sleight P; Eikelboom JW; Bassand JP
N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
[No Abstract] [Full Text] [Related]
10. Enoxaparin experience in percutaneous coronary intervention.
Somani V; Trivedi S
J Indian Med Assoc; 2008 Jan; 106(1):12-5. PubMed ID: 18705262
[TBL] [Abstract][Full Text] [Related]
11. Fondaparinux: an overview.
Nadar SK; Goyal D; Shantsila E; Banerjee P; Lip GY
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):577-85. PubMed ID: 19505272
[TBL] [Abstract][Full Text] [Related]
12. Unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.
Moliterno DJ
Catheter Cardiovasc Interv; 2011 Feb; 77(2):191-2. PubMed ID: 21290553
[No Abstract] [Full Text] [Related]
13. Is thrombogenesis related to residual platelet function in ischaemic heart disease?
Pastor-Pérez FJ; Marín F; Manzano-Fernández S; Lip GY
Eur Heart J; 2008 Dec; 29(24):3065; author reply 3065-6. PubMed ID: 18953049
[No Abstract] [Full Text] [Related]
14. Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
Gallo R; Steinhubl SR; White HD; Montalescot G;
Catheter Cardiovasc Interv; 2009 Feb; 73(3):319-25. PubMed ID: 19213086
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins in percutaneous coronary interventions.
Kar AK; Dutta I
Indian Heart J; 2003; 55(1):81-7. PubMed ID: 12760596
[No Abstract] [Full Text] [Related]
16. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
Montalescot G; Cohen M; Salette G; Desmet WJ; Macaya C; Aylward PE; Steg PG; White HD; Gallo R; Steinhubl SR;
Eur Heart J; 2008 Feb; 29(4):462-71. PubMed ID: 18276619
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin for the prevention of venous thromboembolism.
Sosis MB
N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636757
[No Abstract] [Full Text] [Related]
18. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin in neurosurgical patients.
Connolly ES; Mocco J
N Engl J Med; 1998 Nov; 339(22):1639-40. PubMed ID: 9867528
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
